Baxter International Inc vs UiPath Inc — how do they compare? Baxter International Inc trades at $21.78 (market cap $11.66B), while UiPath Inc trades at $11.98 (market cap $6.14B). The key difference: Baxter International Inc is the larger of the two by market cap, and Baxter International Inc pays a 0.89% dividend while UiPath Inc pays none. Which is the better fit depends on your goals.
| BAX | PATH | |
|---|---|---|
Market Cap | $11.66B | $6.14B |
Sector | Health | Technology |
52-Week High | $29.22 | $19.29 |
52-Week Low | $15.80 | $9.38 |
Enterprise Value | $19.33B | $4.92B |
Dividend Yield | 0.89% | — |
Trailing returns across standard periods
Latest headlines on both assets
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →